1. Can axillary lymph node dissection be avoided in patients with locally advanced breast cancer following neoadjuvant chemotherapy?. (April 2018) Authors: Emirikci, S.; Cabioglu, N.; Trabulus, D.; Ozkurt, E.; Tukenmez, M.; Dogan, S.; Igci, A.; Ozmen, V.; Dinccag, A.; Muslumanoglu, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy. (March 2019) Authors: Cabioglu, N.; Onder, S.; Oner, G.; Karatay, H.; Özkurt, E.; CanTrablus, D.; Tukenmez, M.; Muslumanoglu, M.; Saip, P.; Yavuz, E. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Factors Determining Local Recurrence in Locally Advanced Breast Cancer Patients who Received Neoadjuvant Chemotherapy and Breast Conserving Surgery. (April 2018) Authors: Can Trabulus, D.; Ozturk, E.; Cabioglu, N.; Dogan, S.; Tukenmez, M.; Emirikci, S.; Igci, A.; Ozmen, V.; Dinccag, A.; Muslumanoglu, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Predictive Factors to Achieve Pathologic Complete Response in Patients with Locally Advanced Breast Cancer in Decision Making for more Conservative Management. (April 2018) Authors: Can Trabulus, D.; Ozkurt, E.; Tukenmez, M.; Onder, S.; Muslumanoglu, M.; Igci, A.; Ozmen, V.; Dinccag, A.; Aydiner, A.; Cabioglu, N. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome. Issue 9 (September 2015) Authors: Karanlik, H.; Ozgur, I.; Cabioglu, N.; Sen, F.; Erturk, K.; Kilic, B.; Onder, S.; Deniz, M.; Yavuz, E.; Aydiner, A. Journal: European journal of surgical oncology Issue: Volume 41:Issue 9(2015:Sep.) Page Start: 1226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sentinel Lymph Node Biopsy in Pure DCIS: Is It Necessary?. (14th May 2012) Authors: Boler, D. E.; Cabioglu, N.; Ince, U.; Esen, G.; Uras, C. Other Names: Galetta D. Academic Editor.; Petroianu A. Academic Editor.; Polydorou A. Academic Editor. Journal: ISRN surgery Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study. (April 2021) Authors: Soran, A.; Dogan, L.; Ozbas, S.; Isık, A.; Trablus, D.; Demirci, U.; Karanlık, H.; Soyder, A.; Dag, A.; Bilici, A.; Dogan, M.; Koksal, H.; Sendur, M.A.N.; Gulcelik, M.A.; Maralcan, G.; Cabioglu, N.; Yeniay, L.; Utkan, Z.; Simsek, T.; Karadurmus, N. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗